USFDA gives nod for commercial production at Zydus Ahmedabad API unit
Ahmedabad: Pharma major Zydus Lifesciences has announced that the company has received Post Application Action Letter from the US Food and Drug Administration (USFDA) for the inspection conducted at the Ahmedabad API facility, confirming that the inspected facility has been considered as ready to commercially manufacture and supply the API. This facility underwent for-cause cGMP surveillance and […]